Francois J. Lebel

2021

In 2021, Francois J. Lebel earned a total compensation of $2.4M as Executive Vice President and Chief Medical Officer at Spectrum Pharmaceuticals, a 7% increase compared to previous year.

Compensation breakdown

Bonus$216,000
Option Awards$1,059,371
Salary$540,000
Stock Awards$392,700
Other$161,960
Total$2,370,031

Lebel received $1.1M in option awards, accounting for 45% of the total pay in 2021.

Lebel also received $216K in bonus, $540K in salary, $392.7K in stock awards and $162K in other compensation.

Rankings

In 2021, Francois J. Lebel's compensation ranked 5,371st out of 12,415 executives tracked by ExecPay. In other words, Lebel earned more than 56.7% of executives.

ClassificationRankingPercentile
All
5,371
out of 12,415
57th
Division
Manufacturing
2,263
out of 5,505
59th
Major group
Chemicals And Allied Products
986
out of 2,375
59th
Industry group
Drugs
878
out of 2,096
58th
Industry
Pharmaceutical Preparations
630
out of 1,546
59th

Pay ratio

Francois J. Lebel's Pay$2,370,031
Median Employee's Pay$158,327
Pay Ratio

15

to 1

In 2021, the annual total compensation of Francois J. Lebel was $2,370,031.

The annual total compensation of the median employee at Spectrum Pharmaceuticals was $158,327.

The ratio of Francois J. Lebel's pay to the pay of median employee was therefore 15 to one.

Source: SEC filing on April 27, 2022.

Lebel's colleagues

We found four more compensation records of executives who worked with Francois J. Lebel at Spectrum Pharmaceuticals in 2021.

2021

Joseph Turgeon

Spectrum Pharmaceuticals

Chief Executive Officer

2021

Thomas Riga

Spectrum Pharmaceuticals

Chief Executive Officer

2021

Kurt Gustafson

Spectrum Pharmaceuticals

Chief Financial Officer

2021

Keith McGahan

Spectrum Pharmaceuticals

Chief Legal Officer

News

You may also like